Skip to main content
Caplight Logo









Stratipath

Stratipath

Private
StockholmHealthcare & Life Scienceshttps://www.stratipath.com/

Last Round

Seed

Jul 26, 2021

Total Funding Raised

$2.39M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Stratipath is a healthtech company that develops AI-based precision diagnostic software for cancer treatment decision support.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

digital pathologyAI diagnosticscomputational pathologycancer diagnosticswhole-slide imagingprognostic gradingdecision support softwareCE-IVDpathology AIbreast cancer screeningvertical SaaSclinical decision supportprecision medicinepathology workflow

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stratipath Comparables

Compare Stratipath with similar companies based on industry and business-model similarity.

Stratipath comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spotlight Medical
88%
Aiosyn
88%
Primaa
87%

Stratipath Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 26, 2021
GrantJan 1, 2020

Key People

Founding team and executive leadership

Mattias Rantalainen

Co-founder & CTO

Founding Team

Fredrik Wetterhall

CEO & Co-founder

Founding Team

Annica Jämtén Ericsson

Chief Operating Officer

Executive Team

Stratipath Investors

Notable investors and investment history

Stratipath investors
InvestorRounds
VinnovaGrant
Nascent InvestSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 162% MoM.

  • Apr 22, 2026

    Monthly visitors grew 297% MoM, reaching 2K.

Stratipath Filings

Explore SEC and related filing metadata, where available.

Stratipath filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stratipath's valuation, stock price, and market status.

Is Stratipath a public or private company?

Stratipath is a private company.

What is the current stock price of Stratipath?

Stratipath is a private company with no public stock price. No recent secondary market data is available.

How much is Stratipath worth (valuation)?

Valuation information for Stratipath is not publicly available.

Can I buy Stratipath stock?

Stratipath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stratipath's last funding round?

Stratipath's most recent funding round was Seed on July 26, 2021.

Who are the main investors in Stratipath?

Key investors in Stratipath include Nascent Invest.

Will Stratipath IPO soon?

No public IPO plans have been announced for Stratipath.

How can I track Stratipath secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stratipath's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersStockholm
Employee Range15
Year Founded2019
Last FundingJul 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?